Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in

Kathleen Chiotos1,2,3, Pranita D Tamma4, Kelly B Flett5

  • 1Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA chiotosk@email.chop.edu.

Insights

Carbapenem-resistant Enterobacteriaceae (CRE) in children are linked to prior antibiotic exposure and surgery. Limiting antipseudomonal antibiotic use may prevent CRE spread in pediatric populations.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance Epidemiology
  • Clinical Microbiology

Background:

  • Carbapenem-resistant Enterobacteriaceae (CRE) pose a growing threat in pediatric healthcare settings.
  • Limited data exist on the specific epidemiology and risk factors for CRE in children within the United States.
  • Understanding these factors is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To identify risk factors associated with colonization or infection by CRE in hospitalized children.
  • To describe the microbiological characteristics, including antimicrobial susceptibility patterns, of pediatric CRE isolates.
  • To inform targeted interventions for CRE prevention in pediatric populations.

Main Methods:

  • A multicenter, matched case-control study was conducted between January 2011 and October 2015.
  • Case patients with CRE were matched 2:1 to control patients with carbapenem-susceptible Enterobacteriaceae (CSE).
  • Multivariable conditional logistic regression was used to analyze risk factors and antimicrobial susceptibility was reported.

Main Results:

  • Prior exposure to antipseudomonal antibiotics (OR, 5.20), previous surgery (OR, 6.30), and mechanical ventilation (OR, 12.4) were significant risk factors for CRE.
  • Pediatric CRE isolates showed low resistance rates to amikacin (5%) and ciprofloxacin (25%).
  • Sixty-three case patients and 126 control patients were included in the analysis.

Conclusions:

  • Antibiotic stewardship, particularly limiting unnecessary antipseudomonal antibiotic use, is a key strategy to prevent CRE emergence in children.
  • Further research into the molecular mechanisms of antibiotic resistance in pediatric CRE is warranted.
  • The findings highlight the importance of targeted interventions in pediatric intensive care settings.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
351
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
354